Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation

Ageing Research Reviews

Volumn 36, Issue , 2017, Pages 11-19

  Rahimifard, Mahban ^a   Maqbool, Faheem ^a,b   Moeini Nodeh, Shermineh ^a   Niaz, Kamal ^a,b   Abdollahi, Mohammad ^a,b   Braidy, Nady ^c   Nabavi, Seyed Mohammad ^d   Nabavi, Seyed Fazel ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Central nervous system; Neuroinflammation; NF B; Polyphenol; Toll like receptor 4

Indexed keywords

ALCOHOL DERIVATIVE; CHEMOKINE; CURCUMIN; CYTOKINE; EPIGALLOCATECHIN GALLATE; FLAVONOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGNAN DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; PHENOL DERIVATIVE; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; RESVERATROL; STAT PROTEIN; STILBENE DERIVATIVE; TOLL LIKE RECEPTOR 4; AUTACOID; POLYPHENOL;

APOPTOSIS; ASTROCYTE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CYTOKINE RELEASE; DRUG MECHANISM; DRUG TARGETING; HUMAN; INTRACELLULAR SIGNALING; MACROPHAGE; MEDIATOR RELEASE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; OLIGOMERIZATION; PHARMACOPHORE; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG DELIVERY SYSTEM; DRUG EFFECTS; INFLAMMATION; METABOLISM; NERVE CELL; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; TRENDS;

ANIMALS; ASTROCYTES; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MICROGLIA; NEURONS; POLYPHENOLS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 85013798977     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2017.02.004     Document Type: Review

References (106)

1. Aggarwal, B.B., Nuclear factor-κB: the enemy within. Cancer Cell 6:3 (2004), 203–208.
2. Akira, S., Uematsu, S., Takeuchi, O., Pathogen recognition and innate immunity. Cell 124:4 (2006), 783–801.
3. Albuquerque, K.F., Marinovic, M.P., Morandi, A.C., Bolin, A.P., Otton, R., Green tea polyphenol extract in vivo attenuates inflammatory features of neutrophils from obese rats. Eur. J. Nutr. 55:3 (2016), 1261–1274.
4. Alfonso-Loeches, S., Pascual-Lucas, M., Blanco, A.M., Sanchez-Vera, I., Guerri, C., Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J. Neurosci. 30:24 (2010), 8285–8295.
5. Archivio, M.D., Filesi, C., Di Benedetto, R., Gargiulo, R., Giovannini, C., Masella, R., Polyphenols, dietary sources and bioavailability. Ann. Ist. Super. Sanita 43:4 (2007), 348–361.
6. Azimi, H., Khakshur, A.A., Abdollahi, M., Rahimi, R., Potential new pharmacological agents derived from medicinal plants for the treatment of pancreatic cancer. Pancreas 44:1 (2015), 11–15.
7. Block, M.L., Zecca, L., Hong, J.S., Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8:1 (2007), 57–69.
8. Buchanan, M.M., Hutchinson, M., Watkins, L.R., Yin, H., Toll-like receptor 4 in CNS pathologies. J. Neurochem. 114:1 (2010), 13–27.
9. Byun, E.H., Fujimura, Y., Yamada, K., Tachibana, H., TLR4 signaling inhibitory pathway induced by green tea polyphenol epigallocatechin-3-gallate through 67-kDa laminin receptor. J. Immunol. 185:1 (2010), 33–45.
10. Byun, E.B., Choi, H.G., Sung, N.Y., Byun, E.H., Green tea polyphenol epigallocatechin-3-gallate inhibits TLR4 signaling through the 67-kDa laminin receptor on lipopolysaccharide-stimulated dendritic cells. Biochem. Biophys. Res. Commun. 426:4 (2012), 480–485.
11. Capiralla, H., Vingtdeux, V., Zhao, H., Sankowski, R., Al-Abed, Y., Davies, P., Marambaud, P., Resveratrol mitigates lipopolysaccharide-and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-(B/STAT signaling cascade. J. Neurochem. 120:3 (2012), 461–472.
12. Caso, J.R., Pradillo, J.M., Hurtado, O., Leza, J.C., Moro, M.A., Lizasoain, I., Toll-like receptor 4 is involved in subacute stress–induced neuroinflammation and in the worsening of experimental stroke. Stroke 39:4 (2008), 1314–1320.
13. Chuang, T.H., Ulevitch, R.J., Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors. Nat. Immunol. 5:5 (2004), 495–502.
14. de Oliveira, M.R., Nabavi, S.F., Daglia, M., Rastrelli, L., Nabavi, S.M., Epigallocatechin gallate and mitochondria—A story of life and death. Pharmacol. Res. 104 (2016), 70–85.
15. Delaney, J.R., Mlodzik, M., TGF-beta activated kinase-1: new insights into the diverse roles of TAK1 in development and immunity. Cell Cycle 5:24 (2006), 2852–2855.
16. Devi, K.P., Malar, D.S., Nabavi, S.F., Sureda, A., Xiao, J., Nabavi, S.M., Daglia, M., Kaempferol and inflammation: from chemistry to medicine. Pharmacol. Res. 99 (2015), 1–10.
17. Divanovic, S., Trompette, A., Atabani, S.F., Madan, R., Golenbock, D.T., Visintin, A., Finberg, R.W., Tarakhovsky, A., Vogel, S.N., Belkaid, Y., Kurt-Jones, E.A., Karp, C.L., Inhibition of TLR-4/MD-2 signaling by RP105/MD-1. J. Endotoxin Res. 11:6 (2005), 363–368.
18. Donnelly, D.J., Popovich, P.G., Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol. 209:2 (2008), 378–388.
19. El-Hage, N., Bruce-Keller, A.J., Yakovleva, T., Bazov, I., Bakalkin, G., Knapp, P.E., Hauser, K.F., Morphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca 2 +] i, NF-κB trafficking and transcription. PLoS One, 3(12), 2008, e4093.
20. Farahani, M.S., Bahramsoltani, R., Farzaei, M.H., Abdollahi, M., Rahimi, R., Plant-derived natural medicines for the management of depression: an overview of mechanisms of action. Rev. Neurosci. 26:3 (2015), 305–321.
21. Farzaei, M.H., Rahimi, R., Abdollahi, M., The role of dietary polyphenols in the management of inflammatory bowel disease. Curr. Pharm. Biotechnol. 16:3 (2015), 196–210.
22. Fiscus, R.R., Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells. Neurosignals 11:4 (2002), 175–190.
23. Gárate, I., García-Bueno, B., Madrigal, J.L., Bravo, L., Berrocoso, E., Caso, J.R., Micó, J.A., Leza, J.C., Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J. Neuroinflamm., 8(1), 2011, 151.
24. Gárate, I., Garcia-Bueno, B., Madrigal, J.L.M., Caso, J.R., Alou, L., Gomez-Lus, M.L., Micó, J.A., Leza, J.C., Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway. Biol. Psychiatry 73:1 (2013), 32–43.
25. Galimberti, D., Scarpini, E., Inflammation and oxidative damage in Alzheimer's disease: friend or foe?. Front. Biosci. 3 (2010), 252–266.
26. García-Bueno, B., Caso, J.R., Leza, J.C., Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms. Neurosci. Biobehav. Rev. 32:6 (2008), 1136–1151.
27. Gendelman, H.E., Neural immunity: friend or foe?. J. Neurovirol. 8:6 (2002), 474–479.
28. Gerlo, S., Kooijman, R., Beck, I.M., Kolmus, K., Spooren, A., Haegeman, G., Cyclic AMP: a selective modulator of NF-κB action. Cell. Mol. Life Sci. 68:23 (2011), 3823–3841.
29. Giovannini, M., Scali, C., Prosperi, C., Bellucci, A., Pepeu, G., Casamenti, F., Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors. Int. J. Immunopathol. Pharmacol. 16:Suppl. 2 (2003), 31–40.
30. Graeber, M.B., Li, W., Rodriguez, M.L., Role of microglia in CNS inflammation. FEBS Lett. 585:23 (2011), 3798–3805.
31. Gupta, S.C., Sundaram, C., Reuter, S., Aggarwal, B.B., Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim. Biophys. Acta 1799:10 (2010), 775–787.
32. Hailer, N.P., Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog. Neurobiol. 84:3 (2008), 211–233.
33. Hanisch, U.K., Kettenmann, H., Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10:11 (2007), 1387–1394.
34. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M.L., Pahwa, J.S., Moskvina, V., Dowzell, K., Williams, A., Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 41:10 (2009), 1088–1093.
35. Hasani-Ranjbar, S., Larijani, B., Abdollahi, M., A systematic review of Iranian medicinal plants useful in diabetes mellitus. Arch. Med. Sci. 4:3 (2008), 285–292.
36. Hasani-Ranjbar, S., Nayebi, N., Larijani, B., Abdollahi, M., A systematic review of the efficacy and safety of Teucrium species; from anti-oxidant to anti-diabetic effects. Int. J. Pharmacol. 6:4 (2010), 315–325.
37. Hasani-Ranjbar, S., Jouyandeh, Z., Abdollahi, M., A systematic review of anti-obesity medicinal plants-an update. J. Diabetes Metab. Dis., 12(1), 2013, 1.
38. Hu, X., Yu, Y., Eugene Chin, Y., Xia, Q., The role of acetylation in TLR4-mediated innate immune responses. Immunol. Cell. Biol. 91:10 (2013), 611–614.
39. Hunot, S., Hirsch, E., Neuroinflammatory processes in Parkinson's disease. Ann. Neurol. 53:S3 (2003), S49–S60.
40. Jacobs, A.H., Tavitian, B., Noninvasive molecular imaging of neuroinflammation. J. Cereb. Blood Flow Metab. 32:7 (2012), 1393–1415.
41. Kaltschmidt, B., Widera, D., Kaltschmidt, C., Signaling via NF-(B in the nervous system. Biochim. Biophys. Acta 1745:3 (2005), 287–299.
42. Kamthong, P.J., Wu, M.C., Inhibitor of nuclear factor-κB induction by cAMP antagonizes interleukin-1-induced human macrophage-colony-stimulating-factor expression. Biochem. J. 356:2 (2001), 525–530.
43. Kawai, T., Adachi, O., Ogawa, T., Takeda, K., Akira, S., Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:1 (1999), 115–122.
44. Kawai, T., Takeuchi, O., Fujita, T., Inoue, J.I., Mühlradt, P.F., Sato, S., Hoshino, K., Akira, S., Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167:10 (2001), 5887–5894.
45. Khan, F., Niaz, K., Maqbool, F., Ismail Hassan, F., Abdollahi, M., Nagulapalli Venkata, K.C., Nabavi, S.M., Bishayee, A., Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients, 8(9), 2016.
46. Koedel, U., Merbt, U.M., Schmidt, C., Angele, B., Popp, B., Wagner, H., Pfister, H.W., Kirschning, C.J., Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses. Am. J. Pathol. 171:1 (2007), 200–213.
47. Kuang, X., Huang, Y., Gu, H.F., Zu, X.Y., Zou, W.Y., Song, Z.B., Guo, Q.L., Effects of intrathecal epigallocatechin gallate, an inhibitor of Toll-like receptor 4, on chronic neuropathic pain in rats. Eur. J. Pharmacol. 676:1 (2012), 51–56.
48. Laird, M.H., Rhee, S.H., Perkins, D.J., Medvedev, A.E., Piao, W., Fenton, M.J., Vogel, S.N., TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J. Leukocyte Biol. 85:6 (2009), 966–977.
49. Lee, J.Y., Lee, J.D., Phipps, S., Noakes, P.G., Woodruff, T.M., Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1G93A mouse model of amyotrophic lateral sclerosis. J. Neuroinflamm., 12(1), 2015, 90.
50. Leonard, B., Maes, M., Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci. Biobehav. Rev. 36:2 (2012), 764–785.
51. Li, Y.W., Zhang, Y., Zhang, L., Li, X., Yu, J.B., Zhang, H.T., Tan, B.B., Jiang, L.H., Wang, Y.X., Liang, Y., Zhang, X.S., Wang, W.S., Liu, H.G., Protective effect of tea polyphenols on renal ischemia/reperfusion injury via suppressing the activation of TLR4/NF-kappaB p65 signal pathway. Gene 542:1 (2014), 46–51.
52. Lin, W.W., Karin, M., A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117:5 (2007), 1175–1183.
53. Lucin, K.M., Wyss-Coray, T., Immune activation in brain aging and neurodegeneration: too much or too little?. Neuron 64:1 (2009), 110–122.
54. Madrigal, J.L., Moro, M.A., Lizasoain, I., Lorenzo, P., Castrillo, A., Boscá, L., Leza, J.C., Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor κB-mediated mechanisms. J. Neurochem. 76:2 (2001), 532–538.
55. Maes, M., Coucke, F., Leunis, J.C., Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome. Neuro Endocrinol. Lett. 28:6 (2007), 739–744.
56. Maqbool, F., Mostafalou, S., Bahadar, H., Abdollahi, M., Review of endocrine disorders associated with environmental toxicants and possible involved mechanisms. Life Sci. 145 (2015), 265–273.
57. Mass, M., Kubera, M., Leunis, J.C., The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuroendocrinol. Lett. 29:1 (2008), 117–124.
58. McCoy, M.K., Tansey, M.G., TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflamm., 5(1), 2008, 45.
59. Medzhitov, R., Preston-Hurlburt, P., Janeway, C.A., A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:6640 (1997), 394–397.
60. Medzhitov, R., Origin and physiological roles of inflammation. Nature 454:7203 (2008), 428–435.
61. Meng, Z., Yan, C., Deng, Q., Gao, D.F., Niu, X.L., Curcumin inhibits LPS-induced inflammation in rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways. Acta Pharmacol. Sin. 34:7 (2013), 901–911.
62. Minguet, S., Huber, M., Rosenkranz, L., Schamel, W.W., Reth, M., Brummer, T., Adenosine and cAMP are potent inhibitors of the NF-κB pathway downstream of immunoreceptors. Eur. J. Immunol. 35:1 (2005), 31–41.
63. Mozaffari, S., Abdollahi, M., A review on the role of oxidative stress and inflammation in necrotizing enterocolitis and benefits of the phosphodiesterase inhibitor pentoxifylline. Int. J. Pharmacol. 9:4 (2013), 245–250.
64. Nabavi, S.F., Daglia, M., Moghaddam, A.H., Habtemariam, S., Nabavi, S.M., Curcumin and liver disease: from chemistry to medicine. Compr. Rev. Food Sci. Food Saf. 13:1 (2014), 62–77.
65. Nabavi, S.F., Thiagarajan, R., Rastrelli, L., Daglia, M., Sobarzo-Sanchez, E., Alinezhad, H., Nabavi, S.M., Curcumin: a natural product for diabetes and its complications. Curr. Top. Med. Chem. 15:23 (2015), 2445–2455.
66. Nabavi, S.F., Tejada, S., Setzer, W.N., Gortzi, O., Sureda, A., Braidy, N., Daglia, M., Manayi, A., Nabavi, S.M., Chlorogenic acid and mental diseases: from chemistry to medicine. Curr. Neuropharmacol., 2016, 10.2174/1570159x14666160325120625.
67. Naj, A.C., Jun, G., Beecham, G.W., Wang, L.S., Vardarajan, B.N., Buros, J., Gallins, P.J., Buxbaum, J.D., Jarvik, G.P., Crane, P.K., Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 43:5 (2011), 436–441.
68. Ning-jing, K., Xiao-na, L., Qin, F., Effect of tea polyphenols on secretion and expression of toll like receptor 4 of human periodontal ligament cells stimulated by lipopolysaccharide. J. Oral Sci. Res., 02, 2015.
69. Okun, E., Griffioen, K.J., Lathia, J.D., Tang, S.C., Mattson, M.P., Arumugam, T.V., Toll-like receptors in neurodegeneration. Brain Res. Rev. 59:2 (2009), 278–292.
70. Pan, W., Yu, C., Hsuchou, H., Kastin, A.J., The role of cerebral vascular NFκB in LPS-induced inflammation: differential regulation of efflux transporter and transporting cytokine receptors. Cell. Physiol. Biochem. 25:6 (2010), 623–630.
71. Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., Beutler, B., Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:5396 (1998), 2085–2088.
72. Rahimifard, M., Navaei-Nigjeh, M., Baeeri, M., Maqbool, F., Abdollahi, M., Multiple protective mechanisms of alpha-lipoic acid in oxidation, apoptosis and inflammation against hydrogen peroxide induced toxicity in human lymphocytes. Mol. Cell. Biochem. 403:1–2 (2015), 179–186.
73. Rizzo, N.O., Maloney, E., Pham, M., Luttrell, I., Wessells, H., Tateya, S., Daum, G., Handa, P., Schwartz, M.W., Kim, F., Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding. Arterioscler Thromb. Vasc. Biol. 30:4 (2010), 758–765.
74. Saeidnia, S., Abdollahi, M., Toxicological and pharmacological concerns on oxidative stress and related diseases. Toxicol. Appl. Pharmacol. 273:3 (2013), 442–455.
75. Saeidnia, S., Abdollahi, M., Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century. Toxicol. Appl. Pharmacol. 271:1 (2013), 49–63.
76. Saha, R.N., Pahan, K., Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid. Redox Signal. 8:5–6 (2006), 929–947.
77. Schaefer, T.M., Desouza, K., Fahey, J.V., Beagley, K.W., Wira, C.R., Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 112:3 (2004), 428–436.
78. Seong, K.J., Lee, H.G., Kook, M.S., Ko, H.M., Jung, J.Y., Kim, W.J., Epigallocatechin-3-gallate rescues LPS-impaired adult hippocampal neurogenesis through suppressing the TLR4-NF-κB signaling pathway in mice. Korean J. Physiol. Pharmacol. 20:1 (2016), 41–51.
79. Sha, S., Xing, X.N., Cao, Y.P., Active immunotherapy facilitates Aβ plaque removal following through microglial activation without obvious T cells infiltrating the CNS. J. Neuroimmunol. 274:1 (2014), 62–70.
80. Sheng, W.S., Hu, S., Feng, A., Rock, R.B., Reactive oxygen species from human astrocytes induced functional impairment and oxidative damage. Neurochem. Res. 38:10 (2013), 2148–2159.
81. Shi, H.T., Dong, L., Jiang, J., Zhao, J.H., Zhao, G., Dang, X.Y., Lu, X.L., Jia, M., Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology 303:1 (2013), 107–114.
82. Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., Kimoto, M., MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:11 (1999), 1777–1782.
83. Stone, K.P., Kastin, A.J., Pan, W., NFĸB is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia. Cell. Physiol. Biochem. 28:1 (2011), 115–124.
84. Tabatabaei-Malazy, O., Larijani, B., Abdollahi, M., A novel management of diabetes by means of strong antioxidants' combination. J. Med. Hypothes. Ideas 7:1 (2013), 25–30.
85. Tabatabaei-Malazy, O., Larijani, B., Abdollahi, M., Targeting metabolic disorders by natural products. J. Diabetes Metab. Disord., 14(1), 2015, 1.
86. Tabner, B.J., Turnbull, S., El-Aganf, O., Allsop, D., Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Curr. Topics Med. Chem. 1:6 (2001), 507–517.
87. Tahara, K., Kim, H.D., Jin, J.J., Maxwell, J.A., Li, L., Fukuchi, K., Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 129:Pt 11 (2006), 3006–3019.
88. Takeda, K., Akira, S., TLR signaling pathways. Semin. Immunol. 16:1 (2004), 3–9.
89. Takeuchi, O., Akira, S., Toll-like receptors; their physiological role and signal transduction system. Int. Immunopharmacol. 1:4 (2001), 625–635.
90. Testa, G., Gamba, P., Badilli, U., Gargiulo, S., Maina, M., Guina, T., Calfapietra, S., Biasi, F., Cavalli, R., Poli, G., Loading into nanoparticles improves quercetin's efficacy in preventing neuroinflammation induced by oxysterols. PLoS One, 9(5), 2014, e96795.
91. Thomson, I., Pooneh salari and mohammad abdollahi. Int. J. Pharmacol. 7:5 (2011), 552–567.
92. Trotta, T., Porro, C., Calvello, R., Panaro, M.A., Biological role of Toll-like receptor-4 in the brain. J. Neuroimmunol. 268:1-2 (2014), 1–12.
93. Tu, C.T., Han, B., Yao, Q.Y., Zhang, Y.A., Liu, H.C., Zhang, S.C., Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression. Int. Immunopharmacol. 12:1 (2012), 151–157.
94. Walter, S., Letiembre, M., Liu, Y., Heine, H., Penke, B., Hao, W., Bode, B., Manietta, N., Walter, J., Schulz-Schüffer, W., Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell. Physiol. Biochem. 20:6 (2007), 947–956.
95. Wang, T., Zhou, H., Xie, H., Mu, Y., Xu, Y., Liu, J., Zhang, X., Epigallocatechin-3-gallate inhibits TF and TNF-alpha expression induced by the anti-beta2GPI/beta2GPI complex in human THP-1 cells. Int. J. Mol. Med. 33:4 (2014), 994–1002.
96. Yakovleva, T., Bazov, I., Watanabe, H., Hauser, K.F., Bakalkin, G., Transcriptional control of maladaptive and protective responses in alcoholics: a role of the NF-κB system. Brain Behav. Immun. 25 (2011), S29–S38.
97. Yang, F., Lim, G.P., Begum, A.N., Ubeda, O.J., Simmons, M.R., Ambegaokar, S.S., Chen, P.P., Kayed, R., Glabe, C.G., Frautschy, S.A., Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 280:7 (2005), 5892–5901.
98. Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., He, J., Chen, Z., Resveratrol reduces the proinflammatory effects and lipopolysaccharide- induced expression of HMGB1 and TLR4 in RAW264.7 cells. Cell Physiol. Biochem. 33:5 (2014), 1283–1292.
99. Youn, H.S., Lee, J.Y., Saitoh, S.I., Miyake, K., Kang, K.W., Choi, Y.J., Hwang, D.H., Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (−)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem. Pharmacol. 72:7 (2006), 850–859.
100. Youn, H.S., Saitoh, S.I., Miyake, K., Hwang, D.H., Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem. Pharmacol. 72:1 (2006), 62–69.
101. Yusuf, N., Nasti, T.H., Meleth, S., Elmets, C.A., Resveratrol enhances cell-Mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis. Mol. Carcinog. 48:8 (2009), 713–723.
102. Zeng, Z., Zhan, L., Liao, H., Chen, L., Lv, X., Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway. Planta Med. 79:2 (2013), 102–109.
103. Zhang, C., Lin, G., Wan, W., Li, X., Zeng, B., Yang, B., Huang, C., Resveratrol, a polyphenol phytoalexin, protects cardiomyocytes against anoxia/reoxygenation injury via the TLR4/NF-kappaB signaling pathway. Int. J. Mol. Med. 29:4 (2012), 557–563.
104. Zhang, Z., Chen, N., Liu, J.B., Wu, J.B., Zhang, J., Zhang, Y., Jiang, X., Protective effect of resveratrol against acute lung injury induced by lipopolysaccharide via inhibiting the myd88-dependent Toll-like receptor 4 signaling pathway. Mol. Med. Rep. 10:1 (2014), 101–106.
105. Zhao, L., Lee, J.Y., Hwang, D.H., Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals. Nutr. Rev. 69:6 (2011), 310–320.
106. Zhu, H., Bian, C., Yuan, J., Chu, W., Xiang, X., Chen, F., Wang, C., Feng, H., Lin, J., Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-(B signaling pathway in experimental traumatic brain injury. J. Neuroinflamm., 11(59.10), 2014, 1186.